As AI drives a frenzied demand for power, area providers and developers find themselves at the center of a race to control ...

Schwab International Dividend Equity ETF earns a buy rating for its low 0.08% expense ratio and defensive sector positioning.

Novo Nordisk made a much higher offer to acquire a biotech Pfizer was already set to buy out. Losing this battle would be more damaging to Pfizer than to Novo Nordisk. Even so, both companies look ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Most teams set a single percentage threshold across the board that’s simple but flawed. A 5% swing in a volatile revenue account might mean nothing, while a 2% movement in an accrued liabilities could ...